Accessibility Menu
Xcelerate logo

Xcelerate(OTC) XCRT

Market Cap$4.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-98%
5 Year-87%
1 Year-31%
1 Month-19%
$0.01
+0.00%
+0.00Today
Xcelerate last closing stock price
MetricPriceDate
Last closeUSD 0.012026-09-04
Xcelerate stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.27%USD 0.012026-08-25
1 month-18.52%USD 0.012026-08-05
3 month+14.05%USD 0.012026-06-04
Year to date+25.71%USD 0.012025-12-31
1 year-31.25%USD 0.022025-09-04
3 year-81.67%USD 0.062023-09-05
5 year-86.7%USD 0.082021-09-03
Since inception-98.43%USD 0.702005-01-25

Xcelerate Financials at a Glance

Market Cap

$4.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-$1.18M

Net Income (TTM)

-$996.57K

EPS (TTM)

$0.00

P/E Ratio

-1.69

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$0.01

Volume

17,500

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.02

Estimated Earnings Date

Aug 6, 2026

XCRT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xcelerate

Xcelerate Inc. specializes in sourcing and integrating engineering expertise and patents for nascent medical technology ventures. The company applies its offerings within regulated clinical settings for evaluation, validation, and real-world implementation.

Products and Services
  • Integration of engineering expertise into medical technology
  • Deployment of technology in clinical settings
  • Comprehensive approach to medical technology creation
Growth Outlook
  • Market demand for innovative medical technologies is increasing
  • Potential for partnerships with healthcare providers and institutions
  • Focus on expanding product offerings in emerging markets
Financial Highlights
  • Recent quarterly net income of -32,325, indicating ongoing operational challenges
  • Trailing twelve months (TTM) revenue of 0, reflecting early-stage development
  • Current ratio of 0.087, suggesting liquidity concerns
Xcelerate Inc. operates in the healthcare sector, specifically within medical care facilities. The company has a market capitalization of approximately $4.4 million, indicating a small but potentially agile player in the medical technology space. Established in 1996 and based in Mauldin, South Carolina, Xcelerate Inc. has undergone significant transformations, including a rebranding from Union Dental Holdings, Inc. The company's focus on integrating engineering expertise into medical technology positions it well to capitalize on the growing demand for innovative healthcare solutions. However, recent financial data reveals challenges, including a net income loss in the latest quarter and a TTM revenue of 0, which may raise concerns for potential investors. The current ratio of 0.087 further highlights liquidity issues that could impact operational flexibility. Despite these challenges, the growth outlook remains promising, with increasing market demand for medical technologies and opportunities for partnerships with healthcare providers. The company’s strategic focus on expanding its product offerings in emerging markets could provide avenues for future revenue generation. Investors may find Xcelerate Inc. an intriguing option within the healthcare sector, particularly for those interested in early-stage medical technology ventures.
AI Generated • Aug 20, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

10

CEO

Michael F. O'Shea

Website

www.xcelerate.global

Headquarters

Mauldin, SC 29662, US

XCRT Financials

Key Financial Metrics (TTM)

Gross Margin

31.96%

Operating Margin

2.90%

Net Income Margin

84.32%

Return on Equity

53.90%

Return on Capital

N/A

Return on Assets

-454.52%

Earnings Yield

-59.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

434.45M

Volume

17.50K

Avg. Volume

58.04K

Financials (TTM)

Gross Profit

-$377.80K

Operating Income

-$34.30K

EBITDA

-$30.92K

Operating Cash Flow

-$493.49K

Capital Expenditure

$0.00

Free Cash Flow

-$493.49K

Cash & ST Invst.

$204.26K

Total Debt

$1.79M

Xcelerate Performance Analysis

Xcelerate annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 1,122,085N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Xcelerate sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-0.7%
Q42025-12-31-422.2%
Q12026-03-31100.0%
Q22026-06-30N/A
Xcelerate annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00175.0%
20232023-12-31USD -0.01200.0%
20242024-12-31USD -0.00-63.6%
20252025-12-31USD -0.0016.7%
Xcelerate sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30100.0%
Q42025-12-31N/A
Q12026-03-31100.0%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$4.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$398.24K

N/A

Employees

12

N/A

Net Income

-$32.33K

+80.0%

EBITDA

-$54.18K

+61.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$204.26K

+172.0%

Total Debt

$1.79M

-10.4%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$1.79M

-10.4%

Return on Assets

-4.55%

N/A

Return on Invested Capital

1.62%

N/A

Free Cash Flow

-$57.68K

-707.2%

Operating Cash Flow

-$57.68K

-707.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PMEDFQscreen Ai Inc.
$0.02+0.00%
BICXBioCorRx Inc.
$0.21+0.00%
BBRRFBlueberries Medical Corp.
$0.01+12.88%
HLYKHealthLynked Corp.
$2.60+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About XCRT

What is the current price of Xcelerate?

Xcelerate is trading at $0.01 per share.

What is the 52-week range for Xcelerate?

Over the past 52 weeks, Xcelerate has traded between $0.01 and $0.02.

How much debt does Xcelerate have?

As of the most recent reporting period, Xcelerate reported total debt of $1.79M.

How much cash does Xcelerate have on hand?

Xcelerate reported $204.26K in cash and cash equivalents in its most recent financial results.

What is Xcelerate’s dividend yield?

Xcelerate does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services